CVS Health Files 8-K
Ticker: CVS · Form: 8-K · Filed: Dec 17, 2024 · CIK: 64803
Sentiment: neutral
Topics: sec-filing, corporate-disclosure
Related Tickers: CVS
TL;DR
CVS filed an 8-K on 12/16/24, mostly standard corporate info.
AI Summary
CVS Health Corporation filed an 8-K on December 16, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing details the company's principal executive offices located at One CVS Drive, Woonsocket, Rhode Island, 02895. No specific financial transactions or material events were detailed in the provided text excerpt.
Why It Matters
This filing indicates routine corporate reporting by CVS Health, providing updates on its operational and financial disclosures to the SEC.
Risk Assessment
Risk Level: low — The filing appears to be a routine disclosure without immediate material impact or new risks.
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- 0000064803 (company) — Central Index Key
- 001-01011 (company) — SEC File Number
- One CVS Drive, Woonsocket, Rhode Island 02895 (company) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for CVS Health Corporation, detailing "Other Events" and "Financial Statements and Exhibits" as of December 16, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on December 16, 2024.
Where are CVS Health Corporation's principal executive offices located?
CVS Health Corporation's principal executive offices are located at One CVS Drive, Woonsocket, Rhode Island, 02895.
What is the SEC File Number for CVS Health Corporation?
The SEC File Number for CVS Health Corporation is 001-01011.
What is the Central Index Key (CIK) for CVS Health Corporation?
The Central Index Key (CIK) for CVS Health Corporation is 0000064803.
Filing Stats: 918 words · 4 min read · ~3 pages · Grade level 12.2 · Accepted 2024-12-16 20:17:00
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
- $1,774,423,242.62 — mum Tender Offer Notes, does not exceed $1,774,423,242.62 (such maximum purchase price, the "Maxi
Filing Documents
- d882067d8k.htm (8-K) — 28KB
- d882067dex991.htm (EX-99.1) — 33KB
- d882067dex992.htm (EX-99.2) — 51KB
- g882067g03a53.jpg (GRAPHIC) — 6KB
- g882067g1214092329823.jpg (GRAPHIC) — 3KB
- g882067g1216211413548.jpg (GRAPHIC) — 1KB
- 0001193125-24-279907.txt ( ) — 261KB
- cvs-20241216.xsd (EX-101.SCH) — 3KB
- cvs-20241216_lab.xml (EX-101.LAB) — 17KB
- cvs-20241216_pre.xml (EX-101.PRE) — 11KB
- d882067d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: December 16, 2024 By: /s/ Thomas F. Cowhey Thomas F. Cowhey Executive Vice President and Chief Financial Officer